Takeda Pharmaceutical Co Sees FY2026 GAAP EPS $0.66.

Benzinga Newsdesk www.benzinga.com Neutral 89.9%

Neg 0% Neu 89.9% Pos 0%

Takeda Pharmaceutical Co (NYSE:TAK) is looking for FY2026 GAAP EPS of $0.66.

Comments

No comments yet. Be the first!